North America Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Indication, and End User

List of Tables

The North America antibody testing market is expected to grow from US$ 3,308.90 million in 2021 to US$ 5,185.67 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028.

The continuously growing burden of chronic diseases on healthcare systems across the world is contributing to the expansion of the antibody testing market in this region. The diagnosis is the first step to any treatment, and test kits are imperative to diagnose any condition to start relevant treatments.

According to the Centers for Disease Control and Prevention (CDC), ~6 in 10 people suffered from at least one chronic disease in the US in 2019. As a result of the growing incidence of various diseases, the demand for antibody testing kits and consumables is increasing as antibody detection is an essential criterion for the diagnosis of several pathogens. Antigen characterization is also vital for understanding and monitoring immune responses to infectious agents and vaccines.

An increase in the prevalence of autoimmune diseases, such as plaque psoriasis, Addison disease, celiac disease - spree (gluten-sensitive enteropathy), dermatomyositis, Graves' disease, Hashimoto thyroiditis, multiple sclerosis, myasthenia gravis, and pernicious anemia is also contributing to the antibody testing market growth in North America. According to the autoimmune report of the International Autoimmune Institute & Bingham Memorial Center for Functional Medicine is recognized as a significant health crisis in the US. 50 million Americans-80% of whom are women-suffer one or more autoimmune conditions. According to a recent NCBI report, the epidemiology analysis of two common autoimmune diseases-systemic lupus erythematosus (SLE) and Sjogren's syndrome-the US has higher prevalence rates than other countries. Thus, rise in the prevalence of diseases and need for early diagnosis for the treatment have compelled manufacturers to launch novel diagnostic kits to cater to unmet demands.

With the new features and technologies, vendors in the North America antibody testing market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America antibody testing market at a promising CAGR during the forecast period.

North America Antibody Testing Market Revenue and Forecast to 2028 (US$ Million)

North America Antibody Testing Market Segmentation

The North America antibody testing market is segmented into products, indication, and end User. Based on product, the market has been categorized as kits, chemicals and reagents, and consumables. The kits segment accounted for the largest market share in 2020. Based on indication, the North America antibody testing market is segmented into infectious diseases, endocrine diseases, oncology, pregnancy, cardiovascular diseases, autoimmune diseases, and others. In 2020, the infectious diseases segment accounted for the largest market share. Based on end user, the North America antibody testing market is segmented into diagnostic laboratories, hospitals, biopharmaceutical companies, and academic and research institutes. In 2020, the diagnostic laboratories accounted for the largest market share. Based on country, the North America antibody testing market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2020.

Abbott ; Abcam plc ; Agilent Technologies, Inc.; BD ; BIO-RAD LABORATORIES INC. ; DiaSorin S.p.A. ; F. HOFFMANN-LA ROCHE LTD. ; THERMO FISHER SCIENTIFIC INC. ; Trinity Biotech ; and ZEUS Scientific are among the leading companies in the North America antibody testing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Cam Locks Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America Cam Locks Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00025437

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Antibody Testing Market - By Products
- 1.3.2 Antibody Testing Market - By Indication
- 1.3.3 Antibody Testing Market - By End User
- 1.3.4 North America Antibody Testing Market - By Country

2. North America Antibody Testing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Antibody Testing Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions

5. North America Antibody Testing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Number of COVID-19 Cases
- 5.1.2 Increasing Prevalence of Chronic Diseases
- 5.1.3 Growing Geriatric Population
5.2 Market Restraints
- 5.2.1 Limitations of Antibody Screening Tests
5.3 Market Opportunities
- 5.3.1 Collaborative & Innovation-Driven Strategies
- 5.3.2 Growth of Healthcare Sector in Emerging Markets
5.4 Future Trends
- 5.4.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
5.5 Impact Analysis

6. Antibody Testing Market - North America Analysis

6.1 North America Antibody Testing Marker Revenue Forecast and Analysis

7. North America Antibody Testing Market Analysis and Forecasts to 2028 Product

7.1 Overview
7.2 North America Antibody Testing, by Products, 2021 & 2028 (% Share)
7.3 Kits
- 7.3.1 Overview
- 7.3.2 Kits: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 7.3.2.1 Serological Test Kits
    - 7.3.2.1.1 Overview
    - 7.3.2.1.2 Serological Test Kits: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 7.3.2.2 Immunoglobulin Kits
    - 7.3.2.2.1 Overview
    - 7.3.2.2.2 Immunoglobulin Kits: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 7.3.2.3 Lateral Flow Assay Kits
    - 7.3.2.3.1 Overview
    - 7.3.2.3.2 Lateral Flow Assay Kits: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
7.4 Chemical and Reagents
- 7.4.1 Overview
- 7.4.2 North America Chemical and Reagents Market Revenue and Forecast to 2028 (USD Million)
7.5 Consumables
- 7.5.1 Overview
- 7.5.2 North America Consumables Market Revenue and Forecast to 2028 (USD Million)

8. North America Antibody Testing Market Analysis - By Indication

8.1 Overview
8.2 North America Antibody Testing Market Revenue Share, by Indication (2021 and 2028)
8.3 Infectious Diseases
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.1 Covid-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Covid-19: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.2 HIV
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 HIV: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.3 Hepatitis
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Hepatitis: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.4 Tuberculosis
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Tuberculosis: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.5 Influenza
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Influenza: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.6 Human Papillomavirus (HPV)
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Human Papillomavirus (HPV): Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.3.2.7 Others
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 Others: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
8.4 Endocrine Diseases
- 8.4.1 Overview
- 8.4.2 Endocrine Diseases: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.4.2.1 Diabetes
    - 8.4.2.1.1 Overview
    - 8.4.2.1.2 Diabetes: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.4.2.2 Thyroid Disorders
    - 8.4.2.2.1 Overview
    - 8.4.2.2.2 Thyroid Disorders: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.4.2.3 Others
    - 8.4.2.3.1 Overview
    - 8.4.2.3.2 Others: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
8.5 Oncology
- 8.5.1 Overview
- 8.5.2 Oncology: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.5.2.1 Breast Cancer
    - 8.5.2.1.1 Overview
    - 8.5.2.1.2 Breast Cancer: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.5.2.2 Melanoma
    - 8.5.2.2.1 Overview
    - 8.5.2.2.2 Melanoma: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.5.2.3 Gastric Cancer
    - 8.5.2.3.1 Overview
    - 8.5.2.3.2 Gastric Cancer: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.5.2.4 Others
    - 8.5.2.4.1 Overview
    - 8.5.2.4.2 Others: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
8.6 Cardiovascular Diseases
- 8.6.1 Overview
- 8.6.2 Cardiovascular Diseases: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
8.7 Pregnancy
- 8.7.1 Overview
- 8.7.2 Pregnancy: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
8.8 Autoimmune Diseases
- 8.8.1 Overview
- 8.8.2 Autoimmune Diseases: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.8.2.1 Rheumatoid Arthritis
    - 8.8.2.1.1 Overview
    - 8.8.2.1.2 Rheumatoid Arthritis: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.8.2.2 Inflammatory Bowel Disease
    - 8.8.2.2.1 Overview
    - 8.8.2.2.2 Inflammatory Bowel Disease: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.8.2.3 Multiple Sclerosis
    - 8.8.2.3.1 Overview
    - 8.8.2.3.2 Multiple Sclerosis: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
  - 8.8.2.4 Others
    - 8.8.2.4.1 Overview
    - 8.8.2.4.2 Others: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
8.9 Other Diseases
- 8.9.1 Overview
- 8.9.2 Other Diseases: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)

9. North America Antibody Testing Market - By End User

9.1 Overview
9.2 Antibody Testing Market, by End User, 2021 and 2028 (%)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 North America Diagnostic Laboratories Market Revenue and Forecast to 2028 (USD Million)
9.4 Hospitals
- 9.4.1 Overview
- 9.4.2 North America Hospitals Market Revenue and Forecast to 2028 (USD Million)
9.5 Biopharmaceutical Companies
- 9.5.1 Overview
- 9.5.2 North America Biopharmaceutical Companies: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 North America, Academic and Research Institutes: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)

10. North America Antibody Testing Market Analysis and Forecasts To 2028 Country Analysis

10.1 North America: Antibody Testing Market
- 10.1.1 Overview
- 10.1.2 North America: Antibody Testing Market, by Country, 2021 & 2028 (%)
  - 10.1.2.1 US: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.1 US: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.2 US: Antibody Testing Market, by Products - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.2.1 US: Antibody Testing Market, by Kits - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.3 US: Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.3.1 US: Antibody Testing Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.3.2 US: Antibody Testing Market, by Endocrine Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.3.3 US: Antibody Testing Market, by Oncology - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.3.4 US: Antibody Testing Market, by Autoimmune Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.1.4 US: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)
  - 10.1.2.2 Canada: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.1 Canada: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.2 Canada: Antibody Testing Market, by Products - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.2.1 Canada: Antibody Testing Market, by Kits - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.3 Canada: Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.3.1 Canada: Antibody Testing Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.3.2 Canada: Antibody Testing Market, by Endocrine Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.3.3 Canada: Antibody Testing Market, by Oncology - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.3.4 Canada: Antibody Testing Market, by Autoimmune Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.2.4 Canada: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)
  - 10.1.2.3 Mexico: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.1 Mexico: Antibody Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.2 Mexico: Antibody Testing Market, by Products - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.2.1 Mexico: Antibody Testing Market, by Kits - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.3 Mexico: Antibody Testing Market, by Indication - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.3.1 Mexico: Antibody Testing Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.3.2 Mexico: Antibody Testing Market, by Endocrine Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.3.3 Mexico: Antibody Testing Market, by Oncology - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.3.4 Mexico: Antibody Testing Market, by Autoimmune Diseases - Revenue and Forecast to 2028 (USD Million)
    - 10.1.2.3.4 Mexico: Antibody Testing Market, by End User - Revenue and Forecast to 2028 (USD Million)

11. North America Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 THERMO FISHER SCIENTIFIC INC.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Abbott
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 BIO-RAD LABORATORIES INC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 BD
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Agilent Technologies, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 DiaSorin S.p.A.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 ZEUS Scientific
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Abcam plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Trinity Biotech
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms